Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity
Sign Up to like & getrecommendations! Published in 2017 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-017-4598-7
Abstract: BackgroundRifaximin has demonstrated efficacy and safety for diarrhea-predominant irritable bowel syndrome (IBS-D).AimTo determine the rifaximin repeat treatment effect on fecal bacterial antibiotic susceptibility.MethodsPatients with IBS in Trial 3 (TARGET 3) study who responded to open-label… read more here.
Keywords: irritable bowel; stool microbial; repeat; bowel syndrome ... See more keywords